全文获取类型
收费全文 | 1277篇 |
免费 | 100篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 97篇 |
妇产科学 | 21篇 |
基础医学 | 210篇 |
口腔科学 | 13篇 |
临床医学 | 138篇 |
内科学 | 284篇 |
皮肤病学 | 22篇 |
神经病学 | 93篇 |
特种医学 | 28篇 |
外科学 | 116篇 |
综合类 | 7篇 |
预防医学 | 104篇 |
眼科学 | 16篇 |
药学 | 71篇 |
中国医学 | 1篇 |
肿瘤学 | 142篇 |
出版年
2023年 | 15篇 |
2022年 | 20篇 |
2021年 | 37篇 |
2020年 | 17篇 |
2019年 | 46篇 |
2018年 | 46篇 |
2017年 | 30篇 |
2016年 | 37篇 |
2015年 | 36篇 |
2014年 | 45篇 |
2013年 | 74篇 |
2012年 | 98篇 |
2011年 | 115篇 |
2010年 | 50篇 |
2009年 | 51篇 |
2008年 | 97篇 |
2007年 | 72篇 |
2006年 | 86篇 |
2005年 | 73篇 |
2004年 | 58篇 |
2003年 | 66篇 |
2002年 | 40篇 |
2001年 | 4篇 |
2000年 | 7篇 |
1999年 | 6篇 |
1998年 | 6篇 |
1997年 | 13篇 |
1996年 | 8篇 |
1995年 | 9篇 |
1994年 | 4篇 |
1993年 | 5篇 |
1992年 | 10篇 |
1991年 | 12篇 |
1990年 | 7篇 |
1989年 | 6篇 |
1988年 | 8篇 |
1987年 | 4篇 |
1985年 | 3篇 |
1983年 | 3篇 |
1982年 | 3篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 4篇 |
1976年 | 2篇 |
1974年 | 2篇 |
1972年 | 11篇 |
1971年 | 2篇 |
1969年 | 5篇 |
1968年 | 6篇 |
1966年 | 2篇 |
排序方式: 共有1380条查询结果,搜索用时 15 毫秒
81.
Speeg-Schatz C Lobstein Y Burget M Berra O Riehl C Hoffmann C 《Binocular vision & strabismus quarterly》2004,19(3):151-158
The authors report their experience in preschool vision screening in the east of France, involving the Mother and Child Welfare Service and the School Health Service, under the administration of the National Ministry of Education. The review underlines the importance of early diagnosis of visual disorders in children before they reach three years of age. They recommend screening of every child at least once before the age of four years. 相似文献
82.
83.
84.
Kinnunen T Buhot C Närvänen A Rytkönen-Nissinen M Saarelainen S Pouvelle-Moratille S Rautiainen J Taivainen A Maillère B Mäntyjärvi R Virtanen T 《European journal of immunology》2003,33(6):1717-1726
We have proposed earlier that the poor capacity of the lipocalin allergen Bos d 2 to stimulate highly allergic subjects' peripheral blood mononuclear cells could be ascribed to endogenous lipocalins and could be related to the allergenic potential of the molecule. Here, we have characterized the proliferative and cytokine responses of human T cell clones against the immunodominant epitope of Bos d 2. We observed, for clone F1-9, that a substitution of aspartic acid for asparagine in the core region of the epitope increased the stimulatory capacity of the peptide about 100-fold in comparison with the natural peptide. For clone K3-2, from a different patient, the substitution of lysine for glutamine or isoleucine for leucine in the core region resulted in about 30-fold and 10-fold increases in the stimulatory capacity of the peptides, respectively. The clones also recognized self-protein-derived peptides but not the peptides derived from other lipocalins. We suggest that the poor recognition of the immunodominant epitope of Bos d 2 can be a factor accounting for Bos d 2-allergic subjects' weak cellular responses. Suboptimal recognition of self and allergen epitopes by T cells may be of significance for the allergenicity of proteins. 相似文献
85.
86.
87.
88.
Benchetrit F Gazagne A Adotevi O Haicheur N Godard B Badoual C Fridman WH Tartour E 《Bulletin du cancer》2003,90(8-9):677-685
Experiments in mice and recent human clinical studies have clearly shown the contribution of CD8+ T lymphocyte in the control of tumor development. CD8+ T lymphocytes are a constitutive component of the immune response during the development of cancer. In murine models, the efficiency of various cancer vaccines mainly depends on their ability to induce CD8+ T lymphocytes. Clinical responses in immunotherapy treated cancer patients have been associated with the presence of antitumor specific CD8+ T lymphocytes. In spontaneous regressive melanomas, intratumor antigen specific CD8+ cytotoxic T cells were expanded suggesting their involvement in the tumor shrinkage. Administration of antitumor specific cytotoxic T clones in mice resulted in antitumor responses which directly demonstrated the therapeutic efficiency of these cells. However, in most cases during cancer progression, the presence of antitumor CD8 T lymphocyte is not associated with clinical responses. Intrinsic functional abnormalities of these cells or a defect of CD8+ T cell migration to the tumor may in part explain their failure to inhibit tumor development. On the other hand, tumors also develop immune escape mechanisms (down modulation of tumor antigens, secretion of immunosuppressive factors, expression of anti-apoptotic molecules by the tumors, or pro-apoptotic factors inducing T cell death) to resist to the CD8+ T cell attack. To circumvent these tumor escape mechanisms, efficient cancer vaccines will have to recruit CD8+ T cells associated with other immune effectors. 相似文献
89.
Judson MA Baughman RP Thompson BW Teirstein AS Terrin ML Rossman MD Yeager H McLennan G Bresnitz EA DePalo L Hunninghake G Iannuzzi MC Johns CJ Moller DR Newman LS Rabin DL Rose C Rybicki BA Weinberger SE Knatterud GL Cherniak R;ACCESS Research Group 《Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders》2003,20(3):204-211
A cohort of 215 sarcoidosis patients from the ACCESS study underwent a clinical evaluation at study enrollment and two years later. Approximately 80% of subjects had an improved or stable FVC, FEV1, chest radiograph determined by Scadding stage, and dyspnea scale. African-Americans had less improvement in FVC than Caucasians (p = 0.04). Patients with erythema nodosum at presentation were more likely to have improvement in the chest radiograph at two-year follow-up (p = 0.007). Patients with a lower annual family income were more likely to worsen with respect to dyspnea (p = 0.01) and more likely to have new organ involvement at two-year follow-up (p = 0.045). The development of new organ involvement over the two year follow-up period was more common in African-Americans compared to Caucasians (p = 0.002) and more likely in those with extrapulmonary involvement at study entry (p = 0.003). There was an excellent concordance between changes in FVC and FEV1 over the two-year period. However, changes in FVC alone were inadequate to describe the change in pulmonary status of the patients, as changes in chest radiographic findings or the level of dyspnea did often but not always move in the same direction as FVC. In conclusion, data from this heterogeneous United States sarcoidosis population indicate that sarcoidosis tends to improve or remain stable over two years in the majority of patients. Several factors associated with improved or worse outcome over two years were identified. 相似文献
90.